In a 27 year old man, subcutaneous self-administration of Melanotan II was followed by sympathomimetic symptoms that needed emergency treatment.
In plain wordsA 27 year old man had stimulant-like symptoms after injecting Melanotan II himself and needed emergency care.
- Peptide
- Melanotan II
- Outcome
- Not applicableSympathomimetic symptoms after self-administration
- Study
n = 1
- Outcome group
- Adverse events · Whole body
- Studied dose
- Dose not stated · subcutaneousAs given in this study (human).
Source sentences
He suffered from sympathomimetic symptoms and was treated with lorazepam, supplemental potassium and intravenous fluid resuscitation.
1 context sentence(design, population, supporting numbers)
We report a case of a 27 year old male, with no relevant medical history, who presented at the emergency department two hours after subcutaneous self-administration of Melanotan II.